ALK-Abelló A/S

alk

ALK-Abelló A/S is an international pharmaceutical company devoted to improve the lives of people with allergies by developing pharmaceuticals products that target the cause of allergy.

ALK-Abelló A/S is the world leader in allergy vaccination (immunotherapy) – a unique treatment including a protective immune response that reduces and potentially halts the allergic reaction.

For further information: www.alk.net

Lundbeckfonden

News

How it can help to give an electric shock  
17. July 2018
1,000 old skeletons to provide new knowledge about brain disorders
17. June 2018
Lundbeck Foundation’s magazine out now
1. June 2018